Abstract: Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
Type:
Grant
Filed:
July 19, 2021
Date of Patent:
November 14, 2023
Assignees:
ANNEXON, INC., APTUIT (VERONA) SRL
Inventors:
Dean R. Artis, Colin P. Leslie, Luca B. Mileo, Claudia Beato, Federico Sorana, Bruno Di Guglielmo, Chiara Padroni
Abstract: The present application provides malonamide compounds, and derivatives thereof (e.g., N-aryl malonamides (NAM), acetamides, oxalamides, and the like), that are useful, for example, for the treatment of acute, chronic/persistent, and/or relapsing infections. Pharmaceutical compositions, methods of treating diseases (e.g., bacterial infections), and methods of reducing bacterial virulence are also provided.
Type:
Grant
Filed:
October 19, 2018
Date of Patent:
August 22, 2023
Assignees:
The General Hospital Corporation, Aptuit (Verona) SRL, An Evotec Company